Eli Lilly lifts 2020 profit view as coronavirus lockdowns fuel profit beat

Eli Lilly and Co beat quarterly profit estimates and raised the top-end of its 2020 earnings forecast on Thursday, benefiting from customers stockpiling on medicines such as its diabetes treatment Trulicity amid the coronavirus pandemic.